Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide

A. D. Varvarigou, A. Leonti, S. Xanthopoulos, G. Delle Fave, S. C. Archimandritis, F. Scopinaro, L. Leondiadis, V. Corleto, O. Schillaci, G. De Vincentis, T. G. Sourlingas, K. E. Sekeri-Pataryas, G. P. Evangelatos

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

A new pentadecapeptide bombesin analogue was prepared by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry. The biological activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin. Labelling of the new biomolecule with Tc-99m yielded a single radioactive species which remained stable at room temperature for eight hours. In a binding assay, the radiolabelled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM). Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys. Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i. The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic (GEP) tumors.

Original languageEnglish
Pages (from-to)317-326
Number of pages10
JournalCancer Biotherapy and Radiopharmaceuticals
Volume17
Issue number3
Publication statusPublished - 2002

Fingerprint

Bombesin
Small Cell Lung Carcinoma
Peptides
Bombesin Receptors
Neoplasms
Small Cell Carcinoma
Nude Mice
Colonic Neoplasms
Muscle Cells
Intestines
Colorectal Neoplasms
Rodentia
Mass Spectrometry
Adenocarcinoma
High Pressure Liquid Chromatography
Electrons
Kidney
Temperature
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Varvarigou, A. D., Leonti, A., Xanthopoulos, S., Delle Fave, G., Archimandritis, S. C., Scopinaro, F., ... Evangelatos, G. P. (2002). Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide. Cancer Biotherapy and Radiopharmaceuticals, 17(3), 317-326.

Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide. / Varvarigou, A. D.; Leonti, A.; Xanthopoulos, S.; Delle Fave, G.; Archimandritis, S. C.; Scopinaro, F.; Leondiadis, L.; Corleto, V.; Schillaci, O.; De Vincentis, G.; Sourlingas, T. G.; Sekeri-Pataryas, K. E.; Evangelatos, G. P.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 17, No. 3, 2002, p. 317-326.

Research output: Contribution to journalArticle

Varvarigou, AD, Leonti, A, Xanthopoulos, S, Delle Fave, G, Archimandritis, SC, Scopinaro, F, Leondiadis, L, Corleto, V, Schillaci, O, De Vincentis, G, Sourlingas, TG, Sekeri-Pataryas, KE & Evangelatos, GP 2002, 'Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide', Cancer Biotherapy and Radiopharmaceuticals, vol. 17, no. 3, pp. 317-326.
Varvarigou AD, Leonti A, Xanthopoulos S, Delle Fave G, Archimandritis SC, Scopinaro F et al. Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide. Cancer Biotherapy and Radiopharmaceuticals. 2002;17(3):317-326.
Varvarigou, A. D. ; Leonti, A. ; Xanthopoulos, S. ; Delle Fave, G. ; Archimandritis, S. C. ; Scopinaro, F. ; Leondiadis, L. ; Corleto, V. ; Schillaci, O. ; De Vincentis, G. ; Sourlingas, T. G. ; Sekeri-Pataryas, K. E. ; Evangelatos, G. P. / Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide. In: Cancer Biotherapy and Radiopharmaceuticals. 2002 ; Vol. 17, No. 3. pp. 317-326.
@article{90ebb154319e49c68b6fe6d7f363938d,
title = "Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide",
abstract = "A new pentadecapeptide bombesin analogue was prepared by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry. The biological activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin. Labelling of the new biomolecule with Tc-99m yielded a single radioactive species which remained stable at room temperature for eight hours. In a binding assay, the radiolabelled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM). Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys. Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i. The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic (GEP) tumors.",
author = "Varvarigou, {A. D.} and A. Leonti and S. Xanthopoulos and {Delle Fave}, G. and Archimandritis, {S. C.} and F. Scopinaro and L. Leondiadis and V. Corleto and O. Schillaci and {De Vincentis}, G. and Sourlingas, {T. G.} and Sekeri-Pataryas, {K. E.} and Evangelatos, {G. P.}",
year = "2002",
language = "English",
volume = "17",
pages = "317--326",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Synthesis, chemical, radiochemical and radiobiological evaluation of a new 99mTc-labelled bombesin-like peptide

AU - Varvarigou, A. D.

AU - Leonti, A.

AU - Xanthopoulos, S.

AU - Delle Fave, G.

AU - Archimandritis, S. C.

AU - Scopinaro, F.

AU - Leondiadis, L.

AU - Corleto, V.

AU - Schillaci, O.

AU - De Vincentis, G.

AU - Sourlingas, T. G.

AU - Sekeri-Pataryas, K. E.

AU - Evangelatos, G. P.

PY - 2002

Y1 - 2002

N2 - A new pentadecapeptide bombesin analogue was prepared by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry. The biological activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin. Labelling of the new biomolecule with Tc-99m yielded a single radioactive species which remained stable at room temperature for eight hours. In a binding assay, the radiolabelled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM). Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys. Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i. The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic (GEP) tumors.

AB - A new pentadecapeptide bombesin analogue was prepared by Fmoc synthesis, purified by HPLC and identified by electron ionization mass spectrometry. The biological activity of the new peptide was tested on isolated human colonic muscle cells and compared to native bombesin. Labelling of the new biomolecule with Tc-99m yielded a single radioactive species which remained stable at room temperature for eight hours. In a binding assay, the radiolabelled peptide showed high affinity for oat-cell carcinoma (Kd = 9.8 nM) and colorectal adenocarcinoma (Kd = 27.2 nM). Biodistribution studies, performed in normal rodents, indicated uptake by organs that normally express bombesin receptors, such as liver, intestines and kidneys. Scintigraphic studies, performed in nude mice transplanted with small cell lung carcinoma and colon cancer cells, showed significant tumor uptake two hours p.i. The new synthetic pentadecapeptide appears to have promise for several malignancies, including oat-cell lung carcinoma, colorectal cancer and gastroenteropancreatic (GEP) tumors.

UR - http://www.scopus.com/inward/record.url?scp=0036062011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036062011&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 317

EP - 326

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 3

ER -